Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
8.77
-0.02 (-0.23%)
Jun 27, 2025, 4:00 PM - Market closed
Immunome Market Cap
Immunome has a market cap or net worth of $763.10 million as of June 27, 2025. Its market cap has decreased by -20.72% in one year.
Market Cap
763.10M
Enterprise Value
450.55M
1-Year Change
-20.72%
Ranking
Category
Stock Price
$8.77
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $763.10M, an increase of 585.06%. That is a compound annual growth rate of 50.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 764.84M | 15.38% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |